Lymphangiosarcoma in late-onset hereditary lymphedema: case report and nosological implications.
Identifieur interne : 005413 ( PubMed/Curation ); précédent : 005412; suivant : 005414Lymphangiosarcoma in late-onset hereditary lymphedema: case report and nosological implications.
Auteurs : H C Andersson [États-Unis] ; D M Parry ; J J MulvihillSource :
- American journal of medical genetics [ 0148-7299 ] ; 1995.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- Adult, Aged, Fatal Outcome, Female, Genes, Dominant, Humans, Lymphangiosarcoma (complications), Lymphangiosarcoma (genetics), Lymphedema (complications), Lymphedema (genetics), Male, Middle Aged, Neoplastic Syndromes, Hereditary (complications), Neoplastic Syndromes, Hereditary (genetics), Pedigree.
- MESH :
- complications : Lymphangiosarcoma, Lymphedema, Neoplastic Syndromes, Hereditary.
- genetics : Lymphangiosarcoma, Lymphedema, Neoplastic Syndromes, Hereditary.
- Adult, Aged, Fatal Outcome, Female, Genes, Dominant, Humans, Male, Middle Aged, Pedigree.
Abstract
Hereditary lymphedemas that are not associated with other malformations usually affect the lower limbs and are inherited in an autosomal dominant fashion. These non-syndromic hereditary lymphedemas are categorized by their age of onset, being either congenital (Milroy disease) or having an onset in childhood or around puberty (Meige disease). We describe a family in which three individuals in three generations had unusually late onset of lymphedema in their mid-twenties or thirties. The proband additionally developed a very rare lymphangiosarcoma. This tumor, usually associated with post-mastectomy lymphedema, has not been described in late-onset hereditary lymphedema. Because of an unusually high incidence of multiple primary tumors in association with lymphangiosarcoma in the literature (approximately 10%) and the proband's own familial cancer background, we speculate that an inherited predisposition to malignancy may underlie the development of lymphedema-associated lymphangiosarcoma.
DOI: 10.1002/ajmg.1320560116
PubMed: 7747790
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :005413
Links to Exploration step
pubmed:7747790Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphangiosarcoma in late-onset hereditary lymphedema: case report and nosological implications.</title><author><name sortKey="Andersson, H C" sort="Andersson, H C" uniqKey="Andersson H" first="H C" last="Andersson">H C Andersson</name><affiliation wicri:level="1"><nlm:affiliation>Interinstitute Medical Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Interinstitute Medical Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland</wicri:regionArea></affiliation></author><author><name sortKey="Parry, D M" sort="Parry, D M" uniqKey="Parry D" first="D M" last="Parry">D M Parry</name></author><author><name sortKey="Mulvihill, J J" sort="Mulvihill, J J" uniqKey="Mulvihill J" first="J J" last="Mulvihill">J J Mulvihill</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1995">1995</date><idno type="RBID">pubmed:7747790</idno><idno type="pmid">7747790</idno><idno type="doi">10.1002/ajmg.1320560116</idno><idno type="wicri:Area/PubMed/Corpus">005413</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005413</idno><idno type="wicri:Area/PubMed/Curation">005413</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005413</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphangiosarcoma in late-onset hereditary lymphedema: case report and nosological implications.</title><author><name sortKey="Andersson, H C" sort="Andersson, H C" uniqKey="Andersson H" first="H C" last="Andersson">H C Andersson</name><affiliation wicri:level="1"><nlm:affiliation>Interinstitute Medical Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Interinstitute Medical Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland</wicri:regionArea></affiliation></author><author><name sortKey="Parry, D M" sort="Parry, D M" uniqKey="Parry D" first="D M" last="Parry">D M Parry</name></author><author><name sortKey="Mulvihill, J J" sort="Mulvihill, J J" uniqKey="Mulvihill J" first="J J" last="Mulvihill">J J Mulvihill</name></author></analytic><series><title level="j">American journal of medical genetics</title><idno type="ISSN">0148-7299</idno><imprint><date when="1995" type="published">1995</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Fatal Outcome</term><term>Female</term><term>Genes, Dominant</term><term>Humans</term><term>Lymphangiosarcoma (complications)</term><term>Lymphangiosarcoma (genetics)</term><term>Lymphedema (complications)</term><term>Lymphedema (genetics)</term><term>Male</term><term>Middle Aged</term><term>Neoplastic Syndromes, Hereditary (complications)</term><term>Neoplastic Syndromes, Hereditary (genetics)</term><term>Pedigree</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Gènes dominants</term><term>Humains</term><term>Issue fatale</term><term>Lymphangiosarcome ()</term><term>Lymphangiosarcome (génétique)</term><term>Lymphoedème ()</term><term>Lymphoedème (génétique)</term><term>Mâle</term><term>Pedigree</term><term>Sujet âgé</term><term>Syndromes néoplasiques héréditaires ()</term><term>Syndromes néoplasiques héréditaires (génétique)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lymphangiosarcoma</term><term>Lymphedema</term><term>Neoplastic Syndromes, Hereditary</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Lymphangiosarcoma</term><term>Lymphedema</term><term>Neoplastic Syndromes, Hereditary</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Lymphangiosarcome</term><term>Lymphoedème</term><term>Syndromes néoplasiques héréditaires</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Fatal Outcome</term><term>Female</term><term>Genes, Dominant</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pedigree</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Gènes dominants</term><term>Humains</term><term>Issue fatale</term><term>Lymphangiosarcome</term><term>Lymphoedème</term><term>Mâle</term><term>Pedigree</term><term>Sujet âgé</term><term>Syndromes néoplasiques héréditaires</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Hereditary lymphedemas that are not associated with other malformations usually affect the lower limbs and are inherited in an autosomal dominant fashion. These non-syndromic hereditary lymphedemas are categorized by their age of onset, being either congenital (Milroy disease) or having an onset in childhood or around puberty (Meige disease). We describe a family in which three individuals in three generations had unusually late onset of lymphedema in their mid-twenties or thirties. The proband additionally developed a very rare lymphangiosarcoma. This tumor, usually associated with post-mastectomy lymphedema, has not been described in late-onset hereditary lymphedema. Because of an unusually high incidence of multiple primary tumors in association with lymphangiosarcoma in the literature (approximately 10%) and the proband's own familial cancer background, we speculate that an inherited predisposition to malignancy may underlie the development of lymphedema-associated lymphangiosarcoma.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7747790</PMID><DateCreated><Year>1995</Year><Month>06</Month><Day>13</Day></DateCreated><DateCompleted><Year>1995</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2005</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0148-7299</ISSN><JournalIssue CitedMedium="Print"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>1995</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>American journal of medical genetics</Title><ISOAbbreviation>Am. J. Med. Genet.</ISOAbbreviation></Journal><ArticleTitle>Lymphangiosarcoma in late-onset hereditary lymphedema: case report and nosological implications.</ArticleTitle><Pagination><MedlinePgn>72-5</MedlinePgn></Pagination><Abstract><AbstractText>Hereditary lymphedemas that are not associated with other malformations usually affect the lower limbs and are inherited in an autosomal dominant fashion. These non-syndromic hereditary lymphedemas are categorized by their age of onset, being either congenital (Milroy disease) or having an onset in childhood or around puberty (Meige disease). We describe a family in which three individuals in three generations had unusually late onset of lymphedema in their mid-twenties or thirties. The proband additionally developed a very rare lymphangiosarcoma. This tumor, usually associated with post-mastectomy lymphedema, has not been described in late-onset hereditary lymphedema. Because of an unusually high incidence of multiple primary tumors in association with lymphangiosarcoma in the literature (approximately 10%) and the proband's own familial cancer background, we speculate that an inherited predisposition to malignancy may underlie the development of lymphedema-associated lymphangiosarcoma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>H C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Interinstitute Medical Genetics Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parry</LastName><ForeName>D M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Mulvihill</LastName><ForeName>J J</ForeName><Initials>JJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Genet</MedlineTA><NlmUniqueID>7708900</NlmUniqueID><ISSNLinking>0148-7299</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017809" MajorTopicYN="N">Fatal Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005799" MajorTopicYN="N">Genes, Dominant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008204" MajorTopicYN="N">Lymphangiosarcoma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009386" MajorTopicYN="N">Neoplastic Syndromes, Hereditary</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>19</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>3</Month><Day>13</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>3</Month><Day>13</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7747790</ArticleId><ArticleId IdType="doi">10.1002/ajmg.1320560116</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005413 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 005413 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:7747790
|texte= Lymphangiosarcoma in late-onset hereditary lymphedema: case report and nosological implications.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:7747790" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |